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The glycine receptor is a well-characterized member of the Cys-loop superfam-
ily of receptor proteins. Upon the binding of agonist the transmembrane pore
opens to allow the passage of chloride ions into the cell. Previous research
has identified agonists that bind with comparable affinity to the receptor’s or-
thosteric binding site, but differ in their ability to open the ion channel pore.
This phenomenon of partial agonism is still poorly understood at atomistic res-
olution. Knowledge of how different agonists modulate the receptor’s response
is not only of fundamental importance, but also has direct implications for drug
design. Previously, on the basis of homology models, we suggested that water-
mediated interactions may play a significant role in determining the binding
modes of agonists. We have extended this approach using the recent cryo-
EM and crystal structures. Our molecular dynamics simulations support our
original hypotheses with respect to the role of water in the binding pocket. In
addition, via the use of Markov State Modelling, we are able to provide a
detailed picture of the complex nature of ligand-protein interactions for the
glycine receptor that may have implications for the interpretation of efficacy
of different agonists.
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Marijuana’s analgesic effects can be attributed to the allosteric modulation of
glycine receptors (GlyRs) by D9-tetrahydrocannabinol (THC). GlyRs are
pentameric ligand-gated chloride channels that control inhibitory neurotrans-
mission in the brainstem and spinal cord. The glycinergic mechanism of
cannabis-induced analgesia is independent of the other psychoactive effects
of THC. Compounds specifically targeting the well-defined THC-binding
site in GlyRs are likely to provide pain relief with fewer unwanted side
effects. Here, we screened over 2 million drug-like molecules from the
ZINC database on an ensemble of a3GlyR structures obtained from molecu-
lar dynamics simulations of the closed-state a3GlyR crystal structure (PDB
ID: 5CFB) and a homology model derived from the open-state a1GlyR
NMR structure (PDB ID: 2M6I). Computational dockings were specifically
targeted to the known THC-binding site in the a3GlyR transmembrane
domain. Each screened compound was ranked based on its total predicted
binding affinity across the ensemble of a3GlyR structures. Top ranked com-
pounds were selected for functional measurements in Xenopus laevis oocytes
expressing human a3GlyR. Several lead candidates have been identified as
strong modulators of a3GlyR, exhibiting positive and/or negative allosteric
effects at micromolar concentrations. Further molecular dynamics simula-
tions of a3GlyR in the presence of modulators revealed that in the closed-
state a3GlyR, potentiating compounds showed an increased probability of
contacting with residue S296 compared to inhibitors occupying the same
THC-binding site. S296 on the third transmembrane helix has been previ-
ously shown to be critical for THC potentiation of GlyRs. In contrast, inhib-
itors showed a higher probability of close contact with residue S241 in the
first transmembrane helix. Interestingly, the adjacent residue I240 has been
previously reported as an inhibitory site. This study suggests that different
interaction residue partners, even within the same binding site, may lead to
distinctly different allosteric modulations in a3GlyR. Research supported
by NIH grants.
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Changes in myofilament function related to HCM-associated mutations
contribute to the diastolic dysfunction observed in the in vivo patient heart
and in intact ventricular preparations from patient samples. HCM mutationsthat are ubiquitously expressed in the heart (e.g. cMyBP-C or cTnT) could
also affect atrial function. Here we investigate whether HCM-associated atrial
myopathy is a consequence of mutation-driven sarcomere dysfunction or re-
sults from atrial remodeling due to the diastolic dysfunction and increased
LV filling pressures. In one HCM patient carrying the Lys814del cMyB-C mu-
tation, changes in sarcomere function (increased myofilament Ca2þ sensitivity
and increased cross bridges detachment rate under isometric conditions) were
similar in atrial and ventricular myofibrils compared to donor preparations.
However, isometric twitch mechanics and kinetics of intact trabeculae from
the right atrium of 4 cMyB-C-mutant patients were unaffected as compared
to trabeculae from non-HCM patients (N=8), or mutation negative HCM pa-
tients (N=3), or HCM patients carrying mutations in beta-myosin (N=2). We
extended the study to HCM mouse models carrying mutations in cTnT. In the
E163R mouse, atrial and ventricular sarcomere kinetics and energetics were
similarly altered compared to WT mice. Isometric ATPase, both at rest and
at maximal Ca2þ-activation and the energy cost of tension generation were
increased in both atrial and ventricular preparations of E163R vs WT. How-
ever, isometric twitch kinetics were prolonged in intact ventricular trabeculae
of E163R mice vs WT while they were unaffected in atrial trabeculae. In the
R92Q mouse model, that is associated with a much more severe degree of LV
diastolic dysfunction and left atrial dilatation compared to the E163R, left
atrial trabeculae showed prolonged twitch contractions, increased sponta-
neous activity and a number of E-C coupling alterations that resemble those
observed in ventricular preparations. HCM-mutations in cMyBP-C and
cTnT induce similar alterations in both atrial and ventricular sarcomeres.
However, likely due to the different working conditions of the two chambers,
sarcomere dysfunction can significantly alter the mechanics and kinetics of
the intact myocardium only in the ventricles. Atrial muscle dysfunction in
HCM is induced by remodeling processes that depend on the increased filling
pressures.
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Omecamtiv mecarbil (OM) is a compound that selectively targets the cardiac
sarcomere and enhances myosin crossbridge (XB) activation and force gener-
ation. Because of these properties OM has been proposed as a treatment for sys-
tolic heart failure in humans, however, there are no studies that have directly
examined the functional effects of OM, at XB level, in remodeled human
failing myocardium. Thus, we tested whether OM differentially impacts con-
tractile properties in failing and donor human myocardium. Isometric force,
myofilament Ca2þ-sensitivity (pCa50), rates of XB detachment (krel), recruit-
ment (kdf), and magnitude of XB recruitment (Pdf) were measured both before
and after OM incubation in chemically-skinned myocardial preparations iso-
lated from failing and donor hearts. Because the failing myocardium exhibited
an enhanced pCa50, dynamic XB parameters were measured at pCa’s 6.6 and
6.3, respectively for failing and donor groups in order to achieve equivalent
levels of activation (~22% and ~35% of maximal force, respectively for pre-
and post-OM incubations). OM incubation did not alter the pCa50 but signifi-
cantly enhanced the sub-maximal force production at forces lower than 50%,
an affect that was less pronounced as Ca2þ levels increased. Furthermore,
OM differentially impacted the contractile properties of failing and donor
myocardium. Specifically, OM-induced force increases were more pronounced
in the failing myocardium (~79% increase vs. ~28% in donor myocardium).
Additionally, the OM-induced slowing of krel and kdf, and increase in Pdf
were also more pronounced in the failing myocardium. Our results suggest
that OM is effective in increasing force generation in myocardium isolated
from failing hearts by increasing XB on-time and enhancing cooperative XB
recruitment.
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Human cardiomyopathiesincludes hypertrophic cardiomyopathy (HCM) and
dilated cardiomyopathy (DCM), which affect 1 in every 500 and 1 in every
250 people respectivelyin the U.S. The highest percentage of disease-causing
